UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Role of Biomarkers Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Vasoactive Intestinal Peptide (VIP) in Chronic and Episodic Migraines: A Meta-Analysis

Acta neurologica Scandinavica, 2024-01, Vol.2024, p.1-10

2024

Volltextzugriff (PDF)

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Lancet neurology, 2016-04, Vol.15 (4), p.382-390

2016

Volltextzugriff (PDF)

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Lancet neurology, 2010-04, Vol.9 (4), p.373-380

2010

Volltextzugriff (PDF)

Preventive Treatment for Episodic Migraine

Neurologic clinics, 2019-11, Vol.37 (4), p.753-770

2019

Volltextzugriff (PDF)

The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations

The American journal of managed care, 2017-11, Vol.23 (17 Suppl), p.S326-S333

2017

Volltextzugriff (PDF)

Preventive migraine treatment

Neurologic clinics, 2009-05, Vol.27 (2), p.429-443

Silberstein, Stephen D

2009

Volltextzugriff (PDF)

Headaches caused by nasal and paranasal sinus disease

Neurologic clinics, 2014-05, Vol.32 (2), p.507-523

2014

Volltextzugriff (PDF)

Trigeminal autonomic cephalalgias other than cluster headache

The Medical clinics of North America, 2013-03, Vol.97 (2), p.321-328

2013

Volltextzugriff (PDF)

MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

Mayo Clinic proceedings, 2011-10, Vol.86 (10), p.948-955

2011

Volltextzugriff (PDF)

The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies

Headache, 2015-01, Vol.55 (1), p.3-20

2015

Volltextzugriff (PDF)

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

Lancet neurology, 2014-11, Vol.13 (11), p.1100-1107

2014

Volltextzugriff (PDF)

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Lancet neurology, 2015-11, Vol.14 (11), p.1081-1090

2015

Volltextzugriff (PDF)

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Lancet neurology, 2015-11, Vol.14 (11), p.1091-1100

2015

Volltextzugriff (PDF)

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Cephalalgia, 2010-07, Vol.30 (7), p.793-803

2010

Volltextzugriff (PDF)

Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review

Headache, 2020-07, Vol.60 (7), p.1259-1272

2020

Volltextzugriff (PDF)

Fremanezumab for the Preventive Treatment of Chronic Migraine

The New England journal of medicine, 2017-11, Vol.377 (22), p.2113-2122

2017

Volltextzugriff (PDF)

Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention

Headache, 2015-03, Vol.55 (S2), p.103-122

2015

Volltextzugriff (PDF)

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

Lancet neurology, 2017-06, Vol.16 (6), p.425-434

2017

Volltextzugriff (PDF)

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study

Cephalalgia, 2011-02, Vol.31 (3), p.271-285

2011

Volltextzugriff (PDF)

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

Journal of headache and pain, 2020-09, Vol.21 (1), p.114-114, Article 114

2020

Volltextzugriff (PDF)

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Headache, 2010-06, Vol.50 (6), p.921-936

2010

Volltextzugriff (PDF)

Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review

Headache, 2019-07, Vol.59 (S2), p.20-32

2019

Volltextzugriff (PDF)

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study

Neurology, 2020-11, Vol.95 (18), p.e2487

2020

Volltextzugriff (PDF)

Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine

Headache, 2018-11, Vol.58 (10), p.1579-1592

2018

Volltextzugriff (PDF)

Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial

Headache, 2019-09, Vol.59 (8), p.1240-1252

2019

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(141)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Role of Biomarkers Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Vasoactive Intestinal Peptide (VIP) in Chronic and Episodic Migraines: A Meta-Analysis

Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Preventive Treatment for Episodic Migraine

The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations

Preventive migraine treatment

Headaches caused by nasal and paranasal sinus disease

Trigeminal autonomic cephalalgias other than cluster headache

MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

The Acute Treatment of Migraine in Adults: The American Headache Society Evidence Assessment of Migraine Pharmacotherapies

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review

Fremanezumab for the Preventive Treatment of Chronic Migraine

Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review

Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study

Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine

Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial

Suchergebnisse filtern